19 Aug EXTHYMIC
Rich Stoner, CEO
Oct. 6 | 9:00am | FLW Ballroom F
San Diego, CA
(Private)
Exthymic is a San Diego-based preclinical cell therapy company dedicated to expanding access to curative cell therapies through the local production of engineered cell therapies like CAR-T in community hospital settings across the United States. Exthymic company is developing a lead CAR-T cell therapy asset, EXT-001, that differentiates on accessibility and affordability. Exthymic’s pipeline is enabled by a next-generation hospital-based production device that addresses patient variability directly to ensure a dose of cell therapy can be produced safely and effectively no matter where the device is located or who is using it. The company is backed by major venture capital investors (Khosla Ventures, Dimension Capital) and ARPA-H (SCOPE project).